Latest Insider Transactions at Apollo Medical Holdings, Inc. (AMEH)
This section provides a real-time view of insider transactions for Apollo Medical Holdings, Inc. (AMEH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Apollo Medical Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Apollo Medical Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2024
|
Brandon Sim CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,626
-0.28%
|
$149,682
$57.87 P/Share
|
|
Sep 10
2024
|
Linda Marsh Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,522
-4.36%
|
$165,534
$47.93 P/Share
|
|
Sep 10
2024
|
Linda Marsh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+11.99%
|
$165,000
$15.35 P/Share
|
|
Sep 10
2024
|
Mitchell W Kitayama Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,522
-16.52%
|
$165,534
$47.93 P/Share
|
|
Sep 10
2024
|
Mitchell W Kitayama Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+34.04%
|
$165,000
$15.35 P/Share
|
|
Sep 09
2024
|
John Chiang Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,565
-18.36%
|
$167,555
$47.35 P/Share
|
|
Sep 09
2024
|
John Chiang Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+36.17%
|
$165,000
$15.35 P/Share
|
|
Sep 09
2024
|
Thomas S. Lam Director |
SELL
Payment of exercise price or tax liability
|
Direct |
11,046
-2.69%
|
$519,162
$47.35 P/Share
|
|
Sep 09
2024
|
Thomas S. Lam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
28,046
+6.4%
|
$504,828
$18.65 P/Share
|
|
Aug 16
2024
|
David Schmidt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
14,409
-60.74%
|
$706,041
$49.76 P/Share
|
|
Aug 14
2024
|
David Schmidt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,409
+23.85%
|
$230,544
$16.88 P/Share
|
|
Aug 13
2024
|
David Schmidt Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+27.68%
|
-
|
|
Aug 13
2024
|
John Chiang Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+29.75%
|
-
|
|
Aug 13
2024
|
Dai, Weili Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+33.07%
|
-
|
|
Aug 13
2024
|
Mitchell W Kitayama Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+25.68%
|
-
|
|
Aug 13
2024
|
Linda Marsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+4.86%
|
-
|
|
Aug 13
2024
|
Matthew Mazdyasni Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,564
+30.01%
|
-
|
|
Aug 01
2024
|
Dinesh M. Kumar Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
794
-0.53%
|
$40,494
$51.57 P/Share
|
|
Aug 01
2024
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
67
-0.37%
|
$3,417
$51.57 P/Share
|
|
Jul 11
2024
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
336
-1.8%
|
$15,120
$45.0 P/Share
|
|
May 16
2024
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,051
-4.45%
|
$289,091
$41.13 P/Share
|
|
May 12
2024
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
636
-3.3%
|
$24,168
$38.89 P/Share
|
|
Apr 14
2024
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,993
-4.81%
|
$319,720
$40.72 P/Share
|
|
Apr 02
2024
|
Chandan Basho COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,692
+8.33%
|
-
|
|
Apr 02
2024
|
Brandon Sim CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
86,305
+8.03%
|
-
|
|
Mar 29
2024
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,507
-3.77%
|
$266,787
$41.99 P/Share
|
|
Mar 29
2024
|
Brandon Sim CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
37,957
-3.84%
|
$1,556,237
$41.99 P/Share
|
|
Jan 23
2024
|
Dinesh M. Kumar Officer |
BUY
Grant, award, or other acquisition
|
Direct |
150,395
+16.26%
|
-
|
|
Dec 15
2023
|
John Vong Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,352
+18.73%
|
-
|
|
Dec 15
2023
|
Dai, Weili Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,650
+50.0%
|
-
|
|
Dec 15
2023
|
Thomas S. Lam Director |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+7.89%
|
-
|
|
Dec 15
2023
|
Linda Marsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,650
+5.23%
|
-
|
|
Dec 15
2023
|
Matthew Mazdyasni Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,750
+50.0%
|
-
|
|
Dec 15
2023
|
David Schmidt Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,750
+50.0%
|
-
|
|
Dec 15
2023
|
John Chiang Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,750
+49.48%
|
-
|
|
Dec 15
2023
|
Kenneth T. Sim Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+7.89%
|
-
|
|
Dec 15
2023
|
Mitchell W Kitayama Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,750
+50.0%
|
-
|
|
Dec 06
2023
|
Mitchell W Kitayama Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-100.0%
|
$247,500
$33.49 P/Share
|
|
Dec 06
2023
|
Mitchell W Kitayama Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$135,000
$18.11 P/Share
|
|
Dec 06
2023
|
David Schmidt Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-100.0%
|
$247,500
$33.49 P/Share
|
|
Dec 06
2023
|
David Schmidt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+50.0%
|
$135,000
$18.11 P/Share
|
|
Nov 30
2023
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-1.31%
|
$2,145
$33.23 P/Share
|
|
Nov 14
2023
|
Allied Physicians Of California, A Profession Medical Corp > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,166,561
-30.75%
|
$98,163,391
$31.58 P/Share
|
|
Jul 11
2023
|
John Vong Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
325
-6.14%
|
$10,400
$32.07 P/Share
|
|
Jul 01
2023
|
John Vong Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,040
-20.28%
|
-
|
|
May 16
2023
|
John Vong Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,560
+14.51%
|
-
|
|
May 16
2023
|
John Vong Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,164
-52.48%
|
-
|
|
May 16
2023
|
Brandon Sim CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
380,053
+29.63%
|
-
|
|
May 16
2023
|
Chandan Basho COO and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
130,732
+38.63%
|
-
|
|
Apr 14
2023
|
Chandan Basho COO and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,494
-3.24%
|
$97,266
$39.06 P/Share
|